Updates to the Prescribing Medicines in Pregnancy database, May 2022

The Prescribing Medicines in Pregnancy database has now been updated to include the following new entries:

• amifampridine - pregnancy category C
• amphotericin B (liposomal) - pregnancy category B2
• alpelisib - pregnancy category D
• avalglucosidase alfa - pregnancy category B1
• axicabtagene ciloleucel - pregnancy category C
• burosumab - pregnancy category B3
• brexucabtagene autoleucel - pregnancy category C
• casirivimab / imdevimab - pregnancy category B2
• COVID-19 Vaccine - elasomeran - pregnancy category B1
• COVID-19 Vaccine - SARS-CoV-2 rS (NVX-CoV2373) - pregnancy category B1
• esketamine - pregnancy category B3
• fibrinogen / thrombin - pregnancy category B2
• finerenone - pregnancy category D
• inclisiran - pregnancy category B1
• infigratinib - pregnancy category D
• lemborexant - pregnancy category B3
• lurbinectedin - pregnancy category D
• lutetium (177Lu) chloride - pregnancy category X
• molnupiravir - pregnancy category D
• nirmatrelvir - pregnancy category B3
• pegvaliase - pregnancy category D
• regdanvimab - pregnancy category B2
• sacituzumab govitecan - pregnancy category D
• sotrovimab - pregnancy category B2
• ticagrelor - pregnancy category B1
• tisagenlecleucel - pregnancy category C
• vericiguat - pregnancy category D
• vortioxetine - pregnancy category B3
• zanubrutinib - pregnancy category D

The following entries have been amended:

• carbimazole - pregnancy category from C to D
• propylthiouracil - pregnancy category from C to D
• COVID-19 Vaccine - BNT162b2 (mRNA) - change of name: COVID-19 vaccine - tozinameran